Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / France

France Pays For Long-Term Illnesses

April 2006 | Company Finance Alert

Patients with chronic illnesses now account for 60% of France's healthcare reimbursement costs, according to CNAM - the national health insurer. Population growth, more retirees and a relaxation of diagnostic criteria have all contributed to the increase. Because products used in the treatment of long-term disease are 100% reimbursed, the rapid increase in the number of patients over the past ten years - more than 50% - is a pressing economic

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Western Europe InsightWestern Europe Channels Western Europe Countries